Clinical trials remain out of reach for many Americans, with only 7% of patients with cancer participating in clinical trials, according to a new report from the American Society of Clinical Oncology’s (ASCO) State of Cancer Care in America series.

Facing a cancer diagnosis can be one of the most stressful times for patients and their loved ones.

Both houses of the Alabama legislature unanimously passed Senate Bill 252 during their session this past spring, with the goal of protecting independent pharmacies from what have been described as predatory business practices by healthcare industry middlemen known as Pharmacy Benefit Managers, or PBMs.

A new paper in the Journal of Clinical and Translational Science finds that travel distance to National Cancer Institute (NCI)-funded sites remains a key barrier for patients wanting to participate in clinical trials or research at these locations.

Starting Jan. 1 of this year, the key federal payment program begun covering CT-based screening for the disease, which followed years of advocacy by the specialty.

Adults under 50 undergoing colonoscopy were found to have a dramatically higher risk of having colorectal cancer when the procedure was done for rectal bleeding.

Daily tracking of moderate to severe symptoms such as vomiting and fatigue between chemotherapy visits could help identify individuals who have a higher likelihood of visiting the ED or requiring inpatient care.

The U.S. government shut down on October 1, 2025, after lawmakers were unable to reach a funding agreement.

Owning and operating three independent pharmacies in Mid-Missouri is not just about medicine.

When a breast cancer patient received her prescription for her oncology medication, she experienced a variety of side effects that made it difficult to continue on that dosage.